9.2 Cyanide, Carbon Monoxide & Organophosphate/Cholinergic Toxins

9.2 Cyanide, Carbon Monoxide & Organophosphate/Cholinergic Toxins

Toxic inhalations and chemical agent exposures represent hyperacute emergencies where severe tissue hypoxia develops despite normal or elevated arterial partial pressure of oxygen. Cyanide and carbon monoxide are classic cellular asphyxiants commonly encountered in structure fires and industrial disasters, while organophosphates and carbamates precipitate catastrophic cholinergic crises through neuromuscular and parasympathetic exhaustion. Emergency medicine pharmacists must rapidly differentiate these toxidromes, initiate target-specific antidotes, and recognize laboratory interferences and treatment boundaries.

---

Cyanide Toxicity: Cellular Asphyxiation & Rapid Antidote Therapy

Cyanide is among the most rapidly lethal poisons known. Common clinical exposure routes include:

1. Smoke Inhalation from Structure Fires: Combustion of synthetic polymers containing carbon and nitrogen (polyurethane foams in furniture, plastics, wool, silk, vinyl, and nylon upholstery) produces high concentrations of hydrogen cyanide gas.
2. Industrial & Chemical Exposures: Metal plating, jewelry cleaning, chemical synthesis, metallurgy, and cyanide salts.
3. Pharmacologic Sources: Prolonged or high-dose continuous intravenous infusions of sodium nitroprusside ($>2\text{ mcg/kg/min}$ for $>48\text{ hours}$, or lower doses in patients with severe hepatic or renal dysfunction). Each molecule of sodium nitroprusside non-enzymatically releases five cyanide ions.
4. Ingestion of Cyanogenic Glycosides: Plants such as cassava root, apricot kernels, bitter almonds, and peach pits contain amygdalin, which gut flora hydrolyze into free cyanide.

Molecular Mechanism: The Cytochrome c Oxidase Blockade

Cyanide diffuses rapidly across cell membranes and binds with high affinity to the ferric iron ($\text{Fe}^{3+}$) moiety of cytochrome $c$ oxidase (Complex IV) within the inner mitochondrial membrane. This binding arrests the terminal step of the mitochondrial electron transport chain, blocking the reduction of molecular oxygen to water:

                               MITOCHONDRIAL ELECTRON TRANSPORT CHAIN BLOCKADE
  ┌─────────────────────────────────────────────────────────────────────────────┐
  │ Complex I ──> Complex II ──> Complex III ──> Complex IV (Cyt c Oxidase) ──x │
  │                                                   ▲                         │
  │                                            CYANIDE BINDS Fe3+               │
  │                                  [Halts Aerobic Respiration & ATP Synthesis] │
  └─────────────────────────────────────────────────────────────────────────────┘

Halting the electron transport chain completely shuts down oxidative phosphorylation. Cells immediately shift to anaerobic glycolysis to generate ATP, resulting in massive lactic acid production. Because peripheral tissues cannot extract or utilize oxygen from circulating oxyhemoglobin, oxygen remains trapped in the venous blood. This state is termed histotoxic hypoxia (cellular asphyxiation):

• Diagnostic Hallmark: Severe high-anion-gap lactic acidosis (lactate often $>8\text{ to }10\text{ mmol/L}$ in fire victims strongly correlates with blood cyanide levels $>40\text{ mcmol/L}$). A plasma lactate level $\ge 10\text{ mmol/L}$ in smoke inhalation victims without severe burns has a sensitivity $>85\%$ for toxic cyanide exposure.
• Venous-Arterial Oxygen Gradient: Markedly narrowed; central venous oxygen saturation ($\text{ScvO}_2$) is characteristically elevated ($>90\%$), and retinal and venous blood appears bright arterial red.

Antidote Resuscitation: Hydroxocobalamin (Cyanokit)

Hydroxocobalamin is the first-line antidote of choice for cyanide toxicity, especially in victims of closed-space structure fires who may have concurrent carbon monoxide poisoning.

• Mechanism: Hydroxocobalamin contains a cobalt ion within a porphyrin ring that binds free cyanide with an affinity higher than that of cytochrome oxidase. The reaction forms cyanocobalamin (Vitamin $\text{B}_{12}$), which is non-toxic and eliminated in the urine via renal filtration.
• Dosing & Administration: Standard adult dose is 5 g IV (two 2.5 g vials, each reconstituted with 100 mL of 0.9% sodium chloride, lactated Ringer's, or $\text{D}_5\text{W}$) infused over 15 minutes. A second 5 g dose can be administered over 15 minutes to 2 hours for patients in cardiac arrest or with refractory hemodynamic instability (maximum cumulative dose 10 g). Pediatric dosing is 70 mg/kg IV (maximum single dose 5 g).
• Adverse Effects: Marked chromaturia (dark red, burgundy urine lasting up to 35 days), widespread reddish skin erythema and mucous membrane discoloration, transient hypertension (due to scavenging of endogenous nitric oxide), and pustular rash.

Alternative & Adjunctive Antidotes: The Nitrite-Thiosulfate Regimen

Before hydroxocobalamin became standard, the traditional Cyanide Antidote Kit comprised amyl nitrite, sodium nitrite, and sodium thiosulfate:

1. Sodium Nitrite (300 mg IV over 5–10 min; pediatrics 6–10 mg/kg):
   • Mechanism: Oxidizes the ferrous iron ($\text{Fe}^{2+}$) in normal hemoglobin to ferric iron ($\text{Fe}^{3+}$), generating methemoglobin (MetHb). Methemoglobin has a higher affinity for cyanide than cytochrome oxidase, drawing cyanide out of mitochondria to form cyanomethemoglobin.
   • ABSOLUTE CONTRAINDICATION in Smoke Inhalation: In victims of fires, co-existing carbon monoxide poisoning creates carboxyhemoglobin (COHb), which impairs oxygen delivery. Inducing methemoglobinemia with sodium nitrite destroys the remaining functional oxygen-carrying capacity, precipitating fatal tissue anoxia. Sodium nitrite also causes severe vasodilation and hypotension.
2. Sodium Thiosulfate (12.5 g IV [50 mL of 25% solution] over 10–30 min):
   • Mechanism: Acts as an exogenous sulfur donor for the endogenous mitochondrial enzyme rhodanese (thiosulfate sulfurtransferase). Rhodanese converts toxic cyanide into thiocyanate, which is 200-fold less toxic and safely excreted in the urine.
   • Clinical Role: Slower onset of action compared to hydroxocobalamin; however, it does not induce methemoglobinemia and can be co-administered safely with hydroxocobalamin or nitrites to enhance clearance.

---

Carbon Monoxide (CO) Poisoning

Carbon monoxide is an odorless, colorless, tasteless, non-irritating toxic gas produced by incomplete combustion of hydrocarbons. Common sources include faulty home furnaces, unvented space heaters, motor vehicle exhaust, generators in enclosed spaces, structure fires, and methylene chloride paint strippers (metabolized to CO by hepatic CYP2E1).

Pathophysiology & The Oxyhemoglobin Shift

1. Extreme Hemoglobin Affinity: CO binds to the iron atom in hemoglobin with 200 to 250 times greater affinity than molecular oxygen, forming carboxyhemoglobin (COHb).
2. Leftward Shift of the Oxyhemoglobin Dissociation Curve: The binding of CO to one of the four heme sites alters hemoglobin's quaternary conformation, dramatically increasing the binding affinity of the remaining three heme sites for oxygen. This prevents oxygen release to hypoxic tissues, severely starving the brain and myocardium of oxygen.
3. Cellular & Mitochondrial Toxicity: Dissolved CO binds myoglobin (reducing cardiac contractility), inhibits mitochondrial cytochrome oxidase, and triggers leukocyte adhesion, xanthine oxidase activation, and lipid peroxidation, culminating in Delayed Neurological Sequelae (DNS) (cognitive deficits, personality changes, parkinsonism developing 2 to 40 days post-exposure).

                          CARBON MONOXIDE ELIMINATION HALF-LIFE DYNAMICS
  ┌─────────────────────────────────────────────────────────────────────────────┐
  │ Ambient Room Air (21% FiO2):              Half-Life ~300 minutes (4–5 hours)│
  │ 100% Normobaric Oxygen (Non-Rebreather):  Half-Life ~60 to 90 minutes       │
  │ Hyperbaric Oxygen (HBO, 2.5 to 3.0 ATA):  Half-Life ~20 to 30 minutes       │
  └─────────────────────────────────────────────────────────────────────────────┘

Clinical Presentation & Diagnostic Evaluation

• Symptoms: Mild toxicity presents with frontal headache, nausea, malaise, and dizziness (often misdiagnosed as viral influenza). Severe toxicity manifests as confusion, syncope, seizures, coma, acute myocardial ischemia, and cardiac arrest. "Cherry-red" skin is an exceedingly rare, late, post-mortem finding and must never be relied upon.
• Standard Pulse Oximetry ($\text{SpO}_2$) is Falsely Normal: Standard two-wavelength pulse oximeters cannot distinguish between oxyhemoglobin and carboxyhemoglobin (both absorb light at 660 nm). A patient dying of severe CO poisoning may demonstrate an $\text{SpO}_2$ of $99\%$.
• Diagnostic Standard: Arterial or venous blood gas with co-oximetry, which measures the actual absorption spectrum across multiple wavelengths to directly calculate percentage carboxyhemoglobin (COHb). Baseline COHb is $<2\%$ in non-smokers and up to $5\text{ to }10\%$ in heavy tobacco smokers.

Oxygen Therapy & Hyperbaric Oxygen (HBO) Protocol

Oxygen is the competitive antagonist that displaces CO from hemoglobin:

• First-Line: Administer 100% normobaric oxygen via a tight-fitting non-rebreather reservoir mask immediately upon suspicion until the patient is completely asymptomatic and COHb is $<5\%$.

Indications for Emergent Hyperbaric Oxygen (HBO at 2.5 to 3.0 ATA)

1. Carboxyhemoglobin level $>25\%$ in non-pregnant patients.
2. Carboxyhemoglobin level $>15\%$ in pregnant patients (fetal hemoglobin binds CO with higher affinity and has slower clearance; fetal death can occur even with mild maternal symptoms).
3. History of loss of consciousness (syncope), transient or prolonged.
4. Neurological deficits, coma, seizures, or persistent altered mental status despite 100% normobaric oxygen.
5. Evidence of acute myocardial ischemia (ischemic ECG changes, chest pain, or elevated cardiac troponin).
6. Severe persistent metabolic acidosis (arterial $\text{pH} < 7.25$).

---

Organophosphate & Carbamate Toxicity: Cholinergic Poisoning

Organophosphates (chlorpyrifos, malathion, parathion, diazinon, and chemical warfare nerve agents such as sarin, VX, soman, and tabun) and carbamates (carbaryl, aldicarb, methomyl) are potent acetylcholinesterase inhibitors.

Pathophysiologic Mechanism & Chemical "Aging"

Acetylcholinesterase (AChE) terminates the neurotransmission of acetylcholine (ACh) at parasympathetic postganglionic muscarinic synapses, autonomic ganglia, skeletal muscle neuromuscular junctions (nicotinic), and the central nervous system. Organophosphates bind to the serine hydroxyl active site of AChE, phosphorylating and inactivating the enzyme. This leads to massive, uncontrolled accumulation of acetylcholine across all cholinergic synapses.

• Irreversible Inhibition & Chemical "Aging": The organophosphate-enzyme bond undergoes spontaneous dealkylation (loss of an alkoxy group) over time. Once this dealkylation occurs, the bond is covalent and irreversible—a process termed chemical aging. Aged AChE cannot be reactivated by oximes; new enzyme must be synthesized by the body over weeks. Soman ages within minutes (~2 minutes), whereas sarin ages over 5 hours and VX over 48 hours.
• Carbamates vs. Organophosphates: Carbamates carbamylate rather than phosphorylate AChE. This bond is spontaneously reversible through hydrolysis within 24 to 48 hours and does NOT undergo chemical aging. Pralidoxime is generally unnecessary in pure carbamate poisoning unless clinical distinction from organophosphates is impossible.

Clinical Presentation: The Cholinergic Toxidrome

Cholinergic crisis is characterized by simultaneous muscarinic, nicotinic, and central nervous system hyperactivity:

1. Muscarinic Excess (SLUDGEM / DUMBELS):
   • D: Defecation / Diarrhea
   • U: Urination
   • M: Miosis (pinpoint pupils)
   • B: Bronchorrhea, Bronchospasm, Bradycardia (The "Killer Bs")
   • E: Emesis
   • L: Lacrimation
   • S: Salivation
2. Nicotinic Excess (MTWTF):
   • M: Muscle fasciculations
   • T: Tachycardia (can precede bradycardia due to sympathetic ganglionic stimulation)
   • W: Weakness
   • T: Tremor
   • F: Flaccid diaphragmatic paralysis and respiratory arrest
3. Central Nervous System: Restlessness, emotional lability, confusion, status epilepticus, and central respiratory center depression.

Antidote Resuscitation: Atropine & Pralidoxime (2-PAM)

Loading diagram...

1. Atropine Sulfate: The Muscarinic Antagonist

• Mechanism: Competitive antagonist at muscarinic acetylcholine receptors. It blocks parasympathetic stimulation, reversing bronchorrhea, bronchospasm, and bradycardia. Atropine has ZERO effect on nicotinic receptors and will not reverse muscle fasciculations, peripheral weakness, or diaphragmatic paralysis.
• Dosing & Escalation: Initial adult dose is 2 to 5 mg IV (pediatrics 0.05 mg/kg). If no clinical improvement occurs within 3 to 5 minutes, double the dose (e.g., 2 mg $\rightarrow$ 4 mg $\rightarrow$ 8 mg $\rightarrow$ 16 mg). In severe organophosphate poisoning, cumulative doses exceeding 100 to 200 mg within 24 hours may be required.
• Primary Resuscitation Endpoint of Atropinization:
  1. Clear breath sounds on auscultation (complete drying of tracheobronchial secretions).
  2. Resolution of bronchospasm.
  3. Heart rate $>80\text{ bpm}$ and systolic BP $>90\text{ mmHg}$.
  • Pitfall: Mydriasis is NOT an endpoint for stopping atropine. Pupillary size responds slowly and may be masked by sympathetic ganglionic tone.
• Maintenance Infusion: Once pulmonary secretions are controlled, initiate a continuous IV infusion delivering 10% to 20% of the total cumulative loading dose per hour.

2. Pralidoxime Chloride (2-PAM): The Oxime Reactivator

• Mechanism: A nucleophilic oxime that attacks the phosphorylated acetylcholinesterase, forming an oxime-phosphate complex that hydrolyzes away, thereby reactivating the functional AChE enzyme. Because it works at nicotinic neuromuscular junctions, it restores skeletal muscle strength and reverses diaphragmatic paralysis. It must be administered before chemical aging occurs.
• Dosing: 1 to 2 g IV bolus infused over 15 to 30 minutes (pediatrics: 20 to 50 mg/kg), followed by a continuous infusion of 500 mg/h (pediatrics: 10 to 20 mg/kg/h). Rapid IV administration can precipitate transient hypertension, laryngeal spasm, and muscle rigidity.

3. Adjunctive Seizure Control

Organophosphate-induced status epilepticus causes profound excitotoxic neuropathology. Treat aggressively with intravenous benzodiazepines (diazepam 5 to 10 mg IV or midazolam 5 to 10 mg IV); avoid phenytoin, which is ineffective for toxin-induced seizures.

---

Cellular Asphyxiants & Cholinergic Antidote Reference Matrix